bupivacaine and chitosan

bupivacaine has been researched along with chitosan in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Bernardo, MV; Blanco, MD; Sastre, RL; Teijón, C; Teijón, JM1
de Araújo, DR; de Melo, NF; de Paula, E; Fraceto, LF; Grillo, R; Rosa, AH1
Barenholz, Y; Cohen, R; Grant, GJ; Kanaan, H1
Allegri, M; Balliano, MA; Corradetti, B; Minardi, S; Taraballi, F; Tasciotti, E; Van Eps, JL; Yazdi, IK1
Al Homsi, R; Ali Abdelkareem, M; Eltahir, S; Ghoneim, MM; Greish, K; Haider, M; Jagal, J; Rawas-Qalaji, MM1
Asadi, AA; Atyabi, F; Habibi, S; HMTShirazi, R; Kiani, M; Mohammadi, T1
Chitumalla, RK; Choi, S; Chung, I; Ha, CS; Jang, J; Jung, Y; Nagella, SR; Park, SY; Yoon, JY1

Other Studies

7 other study(ies) available for bupivacaine and chitosan

ArticleYear
Sustained release of bupivacaine from devices based on chitosan.
    Farmaco (Societa chimica italiana : 1989), 2003, Volume: 58, Issue:11

    Topics: Bupivacaine; Chitin; Chitosan; Delayed-Action Preparations

2003
Polymeric alginate nanoparticles containing the local anesthetic bupivacaine.
    Journal of drug targeting, 2010, Volume: 18, Issue:9

    Topics: Alginates; Anesthetics, Local; Animals; Bupivacaine; Chitosan; Drug Stability; Glucuronic Acid; Hexuronic Acids; In Vitro Techniques; Male; Mice; Nanoparticles; Particle Size; Succinates

2010
Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2

    Topics: Alginates; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Chitosan; Cross-Linking Reagents; Drug Carriers; Drug Design; Drug Stability; Drug Storage; Electric Stimulation; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Subcutaneous; Liposomes; Male; Mice; Time Factors

2012
Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.
    Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:11

    Topics: Anesthetics, Local; Animals; Bupivacaine; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; Inflammation Mediators; Kinetics; Lactic Acid; Macrophages; Mice; Particle Size; Phagocytosis; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Technology, Pharmaceutical

2014
Thermosensitive injectable graphene oxide/chitosan-based nanocomposite hydrogels for controlling the in vivo release of bupivacaine hydrochloride.
    International journal of pharmaceutics, 2022, Jun-10, Volume: 621

    Topics: Animals; Bupivacaine; Chitosan; Graphite; Hydrogels; Nanogels; Rats

2022
A bilayer mupirocin/bupivacaine-loaded wound dressing based on chitosan/poly (vinyl alcohol) nanofibrous mat: Preparation, characterization, and controlled drug release.
    International journal of biological macromolecules, 2023, Jun-15, Volume: 240

    Topics: Anti-Bacterial Agents; Bandages; Bupivacaine; Chitosan; Drug Liberation; Mupirocin; Nanofibers; Polyvinyl Alcohol; Staphylococcus aureus

2023
Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine.
    International journal of molecular sciences, 2023, Nov-17, Volume: 24, Issue:22

    Topics: Bupivacaine; Chitosan; Drug Carriers; Hydrogen-Ion Concentration; Nanogels; Nanoparticles

2023